HeartSciences Change in Accounts Receivable 2022-2025 | HSCS

HeartSciences change in accounts receivable from 2022 to 2025. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
HeartSciences Annual Change in Accounts Receivable
(Millions of US $)
2024 $N/A
2023 $0
2022 $0
2021 $N/A
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.004B $0.000B
Heart Test Laboratories, Inc. d/b/a HeartSciences is a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG's clinical utility. Millions of ECGs are performed every week and the Company's objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. HeartSciences has one of the largest libraries of AI-ECG algorithms and is developing AI-ECG solutions to be made available on either a hardware agnostic cloud-based platform or its proprietary MyoVista? wavECG(TM) device, to help identify cardiovascular disease in any care setting worldwide in a manner to best suit different care providers. HeartSciences' first product candidate for FDA clearance, the MyoVista? wavECG(TM), or the MyoVista(R), is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.227B 59.07
Hims & Hers Health (HIMS) United States $12.367B 128.49
Tempus AI (TEM) United States $12.011B 0.00
IRhythm Technologies (IRTC) United States $4.742B 0.00
Inspire Medical Systems (INSP) United States $4.033B 63.01
Hinge Health (HNGE) United States $2.855B 0.00
Privia Health (PRVA) United States $2.804B 191.67
Schrodinger (SDGR) United States $1.917B 0.00
Enovis (ENOV) United States $1.916B 10.69
Phreesia (PHR) United States $1.667B 0.00
Clover Health Investments (CLOV) United States $1.522B 0.00
Omnicell (OMCL) United States $1.463B 25.82
Azenta (AZTA) United States $1.393B 64.72
10x Genomics (TXG) United States $1.311B 0.00
Fulgent Genetics (FLGT) United States $0.663B 0.00
Butterfly Network (BFLY) United States $0.645B 0.00
Claritev (CTEV) United States $0.631B 0.00
Talkspace (TALK) United States $0.499B 149.00
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.410B 0.00
TruBridge (TBRG) United States $0.372B 824.33
Outset Medical (OM) United States $0.366B 0.00
Health Catalyst (HCAT) United States $0.288B 0.00
Nyxoah SA (NYXH) Belgium $0.266B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.199B 0.00
KORU Medical Systems (KRMD) United States $0.148B 0.00
Pulmonx (LUNG) United States $0.137B 0.00
EUDA Health Holdings (EUDA) Singapore $0.124B 0.00
American Well (AMWL) United States $0.115B 0.00
MDxHealth SA (MDXH) Belgium $0.102B 0.00
CareCloud (CCLD) United States $0.094B 3.60
111 (YI) China $0.070B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Zhongchao (ZCMD) China $0.034B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.030B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
Precipio (PRPO) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00